Wells Fargo & Company »

Neurogene shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $24k 471 50.90
2023-12-31 $8.0k 414 19.38